Latest News and Press Releases
Want to stay updated on the latest news?
-
MONROVIA, Calif., March 03, 2022 (GLOBE NEWSWIRE) -- CytoImmune Therapeutics, a clinical-stage cell-therapy company developing a novel class of tumor-reactive engineered natural killer cell-based...
-
MONROVIA, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) -- CytoImmune Therapeutics, a clinical-stage cell therapy company that is developing a novel class of tumor-reactive engineered natural killer...
-
TOA BAJA, Puerto Rico, Jan. 25, 2022 (GLOBE NEWSWIRE) -- CytoImmune Therapeutics, a clinical-stage immunotherapy company that is developing a novel class of natural killer (NK) cell-based cancer...
-
TOA BAJA, Puerto Rico, Dec. 14, 2021 (GLOBE NEWSWIRE) -- CytoImmune Therapeutics, a clinical-stage cell immunotherapy company developing novel natural killer (NK) cell therapies to fight cancer,...
-
CytoImmune Therapeutics Appoints Renowned Oncologist and Immunologist as New Chief Executive Officer
LOS ANGELES, Nov. 10, 2021 (GLOBE NEWSWIRE) -- CytoImmune Therapeutics, a privately-held cell therapy company focused on developing natural killer (NK) immune cells to fight cancer, announces the...